Award recordCONTRACT

NOVO NORDISK INC

PIID VA797P15C0039· VA Staff Offices· NAC PHARMACEUTICALS (36E797)· 6505 · DRUGS AND BIOLOGICALS· FY2015· $0 net obligations· UEI W72BJMJYBMN3· NJ

Description

2020 SUBCONTRACTING PLAN

Base award description: AWARD OF HUMAN INSULIN, BASE YEAR PLUS 4 ONE YEAR OPTION PERIODS

First action · last action
2015-05-28 · 2019-12-23
Transactions
12
First transaction's obligation
$0
Base + all options value (sum of deltas)
$532,607,180
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 12 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2015-05-28 · this action $0 · running total $0Modification P00001 · 2016-01-05 · this action $0 · running total $0Modification P00002 · 2016-06-07 · this action $0 · running total $0Modification P00003 · 2016-12-22 · this action $0 · running total $0Modification P00005 · 2017-05-19 · this action $0 · running total $0Modification P00006 · 2017-10-13 · this action $0 · running total $0Modification P00007 · 2017-12-01 · this action $0 · running total $0Modification P00008 · 2018-06-04 · this action $0 · running total $0Modification P00009 · 2018-12-26 · this action $0 · running total $0Modification P00010 · 2019-05-15 · this action $0 · running total $0Modification P00011 · 2019-09-12 · this action $0 · running total $0Modification P00012 · 2019-12-23 · this action $0 · running total $0
  • Base2015-05-28+$0= $0
  • Mod P000012016-01-05+$0= $0
  • Mod P000022016-06-07+$0= $0
  • Mod P000032016-12-22+$0= $0
  • Mod P000052017-05-19+$0= $0
  • Mod P000062017-10-13+$0= $0
  • Mod P000072017-12-01+$0= $0
  • Mod P000082018-06-04+$0= $0
  • Mod P000092018-12-26+$0= $0
  • Mod P000102019-05-15+$0= $0
  • Mod P000112019-09-12+$0= $0
  • Mod P000122019-12-23+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-05-28+$0$0AWARD OF HUMAN INSULIN, BASE YEAR PLUS 4 ONE YEAR OPTION PERIODS
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2016-01-05+$0$0INCORPORATING THE 2016 SUBCONTRACTING PLAN
Mod P00002· EXERCISE AN OPTION2016-06-07+$0$0EXERCISE OPTION YEAR 1 PERFORMANCE PERIOD 07/01/2016 - 06/30/2017 3 ONE YEAR OPTIONS REMAIN
Mod P00003· OTHER ADMINISTRATIVE ACTION2016-12-22+$0$02017 SUBCONTRACTING PLAN COMMERCIAL COMPANY WIDE SUBCONTRACTING PLAN INTO THE NATIONAL CONTRACT.
Mod P00005· EXERCISE AN OPTION2017-05-19+$0$0EXERCISE OPTION YEAR 2 FOR HUMAN INSULIN WITH NOVO NORDISK, INC.
Mod P00006· OTHER ADMINISTRATIVE ACTION2017-10-13+$0$0ADMINISTRATIVE AND SIGNATORY AUTHORITY POINT OF CONTACT CHANGES FOR CONTRACT NUMBER VA797P-15-C-0039
Mod P00007· ADD SUBCONTRACTING PLAN2017-12-01+$0$02018 SUBCONTRACTING PLAN COMMERCIAL COMPANY WIDE SUBCONTRACTING PLAN INTO THE NATIONAL CONTRACT
Mod P00008· EXERCISE AN OPTION2018-06-04+$0$0OPTION YEAR THREE HUMAN INSULIN
Mod P00009· ADD SUBCONTRACTING PLAN2018-12-26+$0$02019 SUBCONTRACTING PLAN
Mod P00010· EXERCISE AN OPTION2019-05-15+$0$0EXERCISE FOURTH AND FINAL OPTION YEAR
Mod P00011· OTHER ADMINISTRATIVE ACTION2019-09-12+$0$0ADD BRIAN CATTIE AS POINT OF CONTACT
Mod P00012· ADD SUBCONTRACTING PLAN2019-12-23+$0$02020 SUBCONTRACTING PLAN

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI W72BJMJYBMN3)

AwardOffice · PSC / listingNet obligationsFY
36E79725A0025NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36F79721D0044NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2021
36E79720D0071NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2020
36E79720D0018NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2020
36F79719D0181NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2019
VA24113F0882241-NETWORK CONTRACT OFFICE 01 · 6505 · DRUGS AND BIOLOGICALS$0FY2013

Other recipients under 6505 from NAC PHARMACEUTICALS (36E797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36E79726A0025CHIESI USA INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0024NEUROTECH PHARMACEUTICALS, INCNAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0023TAKEDA PHARMACEUTICALS AMERICA, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726D0041GOLDEN STATE MEDICAL SUPPLY, INC.NAC PHARMACEUTICALS (36E797)$0FY2026
36E79726A0022AURINIA PHARMA US INCNAC PHARMACEUTICALS (36E797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA797P15C0039_3600 · retrieved 2026-09-26.